Hemophilia is a bleeding disorder caused by insufficient clotting factor in the blood. The level of severity depends on the amount of clotting factor missing. People with hemophilia often experience prolonged bleeding and for those with severe hemophilia, this can lead to permanent joint damage and life-threatening hemorrhages. The standard treatment for people with hemophilia involves management of acute bleeding and prophylaxis, the regular administration of clotting factor concentrates, to prevent bleeds. New and emerging therapies such as monoclonal antibodies and gene therapy are giving hope to those living with hemophilia.
At the end of this session, you will understand:
- Describe the types and symptoms of hemophilia
- Outline the diagnosis and common treatments for hemophilia
- Discuss emerging therapies and implications for the lab of tomorrow
Speaker : Alysa Rossman, BSc